Another study found that UDCA can also inhibit IGF-1-induced activation of AKT and ERK, which are key pathways involved in regulating the proliferation of cholangiocarcinoma cells (Lee et al. 2019). The gene discussed is EPHB2; the disease is cholangiocarcinoma.